Document is current

Any future updates will be listed below

Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC)

Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P98

Published Online: 2014-11-06

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark